Page last updated: 2024-08-24

irinotecan and Cystadenocarcinoma, Serous

irinotecan has been researched along with Cystadenocarcinoma, Serous in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (75.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bodurka, DC; Gano, J; Gershenson, DM; Kavanagh, JJ; Levenback, C; Wharton, JT; Wolf, JK	1
Hata, K; Higuchi, M; Kajino, T; Shibata, N	1
Shimizu, Y	1
Fujimura, M; Fushiki, H; Hidaka, T; Hori, S; Izumi, R; Yamakawa, Y	1

Reviews

1 review(s) available for irinotecan and Cystadenocarcinoma, Serous

Article	Year
Individualized chemotherapeutic regimen for each histological subtype of ovarian carcinoma. Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24 Suppl 1 Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma; Carcinoma, Endometrioid; Carcinoma, Transitional Cell; Cisplatin; Cystadenocarcinoma, Serous; Drug Resistance, Neoplasm; Female; Humans; Irinotecan; Mitomycin; Ovarian Neoplasms	1997

Article

Year

Individualized chemotherapeutic regimen for each histological subtype of ovarian carcinoma.

Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24 Suppl 1

Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma; Carcinoma, Endometrioid; Carcinoma, Transitional Cell; Cisplatin; Cystadenocarcinoma, Serous; Drug Resistance, Neoplasm; Female; Humans; Irinotecan; Mitomycin; Ovarian Neoplasms

1997

Trials

1 trial(s) available for irinotecan and Cystadenocarcinoma, Serous

Article	Year
Phase II trial of irinotecan in patients with metastatic epithelial ovarian cancer or peritoneal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Jan-15, Volume: 21, Issue:2 Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Antineoplastic Agents, Phytogenic; CA-125 Antigen; Camptothecin; Carcinoma, Papillary; Cystadenocarcinoma, Serous; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Immunoenzyme Techniques; Infusions, Intravenous; Irinotecan; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Peritoneal Neoplasms	2003

Article

Year

Phase II trial of irinotecan in patients with metastatic epithelial ovarian cancer or peritoneal cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Jan-15, Volume: 21, Issue:2

Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Antineoplastic Agents, Phytogenic; CA-125 Antigen; Camptothecin; Carcinoma, Papillary; Cystadenocarcinoma, Serous; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Immunoenzyme Techniques; Infusions, Intravenous; Irinotecan; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Peritoneal Neoplasms

2003

Other Studies

2 other study(ies) available for irinotecan and Cystadenocarcinoma, Serous

Article	Year
[Combination therapy with irinotecan and CBDCA for patients in terminal stage of ovarian carcinoma]. Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cystadenocarcinoma, Serous; Drug Administration Schedule; Female; Humans; Irinotecan; Leukopenia; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Thrombocytopenia	1996
[Evaluation of a new anti-cancer drug regimen for surface epithelial-stromal ovarian cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:5 Topics: Adenoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Cyclophosphamide; Cystadenocarcinoma, Serous; Doxorubicin; Female; Humans; Irinotecan; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Paclitaxel; Tumor Cells, Cultured	1998

Article

Year

[Combination therapy with irinotecan and CBDCA for patients in terminal stage of ovarian carcinoma].

Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:1

Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cystadenocarcinoma, Serous; Drug Administration Schedule; Female; Humans; Irinotecan; Leukopenia; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Thrombocytopenia

1996

[Evaluation of a new anti-cancer drug regimen for surface epithelial-stromal ovarian cancer].

Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:5

Topics: Adenoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Cyclophosphamide; Cystadenocarcinoma, Serous; Doxorubicin; Female; Humans; Irinotecan; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Paclitaxel; Tumor Cells, Cultured

1998